Susquehanna Portfolio Strategies, LLC
Position in MYGN — Myriad Genetics Inc
CIK 1996449
Bala Cynwyd, PA
Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,638,693
-$720,797 QoQ
Shares Held
364,154
-5.1% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Susquehanna Portfolio Strategies, LLC holds $78,773,831 across 9 Diagnostics & Research names. MYGN ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
360,498 | $41,089,562 | |
| 2 | ILMN |
Illumina, Inc.
|
104,441 | $12,873,397 | |
| 3 | GH |
Guardant Health, Inc.
|
108,479 | $10,020,205 | |
| 4 | DGX |
Quest Diagnostics Inc
|
32,993 | $6,465,968 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
374,269 | $5,194,853 | |
| 6 | MYGN |
Myriad Genetics Inc
This page
|
364,154 | $1,638,693 | |
| 7 | GRAL |
GRAIL, Inc.
|
12,420 | $641,865 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
28,859 | $458,858 |
All Filings in MYGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,638,693 | 364,154 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,359,490 | 383,657 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,773,840 | 383,657 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,422,103 | 456,140 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||